24 October 2025, Over the past 20 years, Dutch hospitals have filed 559 European patent applications. This emerges from a new study by the European Patent Office and Fraunhofer ISI, highlighting the growing role of public research organizations (PROs) in European innovation.
Patent applications are an important measure of innovation: they reflect both the intention and the effort to develop new inventions, according to the Patent Office.
Direct Applications
Where hospitals previously mainly supported patent applications from third parties, indirectly, they are now increasingly filing patents themselves. In the Netherlands, 60 percent of hospital applications are now direct filings, giving them the highest share in Europe.
LUMC
This demonstrates the strong technology transfer within Dutch research hospitals, with the Leiden University Medical Center (LUMC) leading in direct applications. The Netherlands Cancer Institute (NKI) accounted for 140 applications, while the Netherlands Organization for Scientific Research (NWO) was responsible for 187 applications.
The publication of the Wennink Report has led to extensive national and regional media coverage on the role of red biotechnology in the future of the Dutch economy and healthcare...
On December 11th Leiden Bio Science Park participated in the International Talent in South Holland Conference, an inspiring event that marked the launch of a new regional...
This strategic move allows us to better integrate into this unique community, empowering us to strengthen collaborations with leading researchers and provide exceptional, on-site support to our partners in life science research and pharmaceutical development.